Report cover image

Rescue Inhaler Market, By Product Type (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers, and Others), By Indication (Asthma, COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension, and Others), By Patient Type (Adult and Pedia

Publisher Coherent Market Insights
Published Mar 27, 2025
Length 180 Pages
SKU # CMI20008817

Description

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient’s quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:
  • This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the rescue inhaler market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market
Rescue Inhaler Market Detailed Segmentation:
  • By Product Type:
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers
  • Soft Mist Inhalers
  • Others
  • By Indication:
  • Asthma
  • COPD
  • Allergic Rhinitis
  • Pulmonary Arterial Hypertension
  • Others
  • By Patient Type:
  • Adult
  • Pediatric
  • By Dosage Form:
  • Capsules
  • Solution
  • Suspension
  • Others
  • By End User:
  • Home Care Settings
  • Hospitals & Clinics
  • By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profile:
  • GSK plc.
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • PARI Pharma GmbH
  • Lupin
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Novartis
  • Pfizer
  • Sunovion Pharmaceuticals
  • 3M
  • Omron Healthcare
  • Koninklijke Philips N.V.
  • Invacare
  • Schiller
  • Teleflex Incorporated

Table of Contents

180 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Indication
Market Snippet, By Patient Type
Market Snippet, By Dosage Form
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Rising prevalence of respiratory diseases
Increasing geriatric population
Increasing Product Approval
Restraints
Stringent regulatory requirements
Product Recall
High cost of inhalers
Opportunities
Rising focus on telehealth for respiratory care
Development of biologics for asthma
High growth potential in emerging markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Rescue Inhaler Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Rescue Inhaler Market, By Product Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Metered Dose Inhalers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Dry Powder Inhalers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Nebulizers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Soft Mist Inhalers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
6. Rescue Inhalers Market, By Indication, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
COPD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Allergic Rhinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Pulmonary Arterial Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Rescue Inhalers Market, By Patient Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
8. Rescue Inhalers Market, By Dosage Form, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Solution
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Suspension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
9. Rescue Inhalers Market, By End User, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
10. Rescue Inhalers Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Country 2021 –2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.S.
Canada
Europe
Asia Pacific
Latin America
Middle East
Africa
11. Competitive Landscape
GSK plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Cipla Inc.
PARI Pharma GmbH
Lupin
AstraZeneca
Boehringer Ingelheim International GmbH.
Novartis
Pfizer
Sunovion Pharmaceuticals
3M
OMRON Healthcare Co., Ltd.
Koninklijke Philips N.V.
Invacare
Schiller
Teleflex Incorporated
Analyst Views
12. Section
Research Methodology
About us
*Browse 53 market data tables and 44 figures on Rescue Inhaler Market” - forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us